Donald G. Payan
2010
In 2010, Donald G. Payan earned a total compensation of $1.9M as Executive Vice President, President of Discovery and Research at Rigel Pharmaceuticals, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,860 |
|---|---|
| Option Awards | $1,187,852 |
| Salary | $507,150 |
| Other | $3,564 |
| Total | $1,901,426 |
Payan received $1.2M in option awards, accounting for 62% of the total pay in 2010.
Payan also received $202.9K in non-equity incentive plan, $507.2K in salary and $3.6K in other compensation.
Rankings
In 2010, Donald G. Payan's compensation ranked 3,224th out of 10,439 executives tracked by ExecPay. In other words, Payan earned more than 69.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,224 out of 10,439 | 69th |
Division Manufacturing | 1,126 out of 3,838 | 71st |
Major group Chemicals And Allied Products | 218 out of 926 | 77th |
Industry group Drugs | 118 out of 685 | 83rd |
Industry Pharmaceutical Preparations | 90 out of 481 | 81st |
Source: SEC filing on April 3, 2013.
Payan's colleagues
We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2010.